Recap: Adam Katz of Research!America- How (and why) to engage Congress as a research scientist

By -
Adam is the Policy and Advocacy Specialist at Research!America, where he leads a variety of advocacy initiatives to make science and medical research a higher national priority. When he visited PSPG on Nov. 12th he spoke about how and why scientists, especially those in academia, should engage in the political system. Academic scientists in particular are heavily supported by federal funding and taxpayers, so it is important to initiate and maintain a dialog between researchers, politicians and the American people. Research!America has conducted numerous polls to understand the relationship between these three groups, and they have found that while Americans believe scientific research should be a top priority, the public does not have a clear understanding of how this research is funded (only a small fraction of those polled identified the NIH as the main source of basic biomedical research funding). Therefore it is important that we as scientists, taxpayers and constituents take it upon ourselves to stress to our politicians the importance of the NIH and its integral role in supporting basic science research. There are many ways to make your voice heard: through email, phone calls and even in person, as PSPG has done twice this year. Mr. Katz gave excellent tips on how to address a congressperson and their staff: thank them for past support, keep it concise, lay out your concerns and follow it with a personal story, ask their opinion and reiterate the action you'd like taken. If this type of science policy work sounds like a potential career path to you, we encourage you to attend our next speaker event on Wednesday Dec. 4th at 12pm featuring Dr. Richard Calderone, director of the M.S. program in Biomedical Science Policy & Advocacy at Georgetown University.


Comments

Post a Comment

Popular posts from this blog

2015 AAAS Science and Technology Policy Forum Summary

By -
I recently had the opportunity to attend the 2015 AAAS Science and Technology Policy Forum in Washington, D.C. This annual meeting brings together a range of academics and professionals to discuss the broad S&T policy landscape. Below are some of my takeaways from the meeting. I hope to have additional comments from other National Science Policy Group members up soon. By Chris Yarosh The talks and panels at the Forum encompassed a huge range of topics from the federal budget and the appropriations outlook to manufacturing policy and, of course, shrimp treadmills . My opinion of the uniting themes tying this gamut together is just that—my opinion— and should only be taken as such. That being said, the threads I picked on in many of the talks can be summarized by three C’s: cooperation, communication, and citizenship . First up, cooperation. Although sequestration’s most jarring impacts have faded, AAAS’s budget guru Matthew Hourihan warns that fiscal year 2016 could
Read more

AAAS Forum Take #2

By -
Another point of view of the AAAS Forum by Matthew Facciani: I have provided scientific testimony and met with some of my local legislators, but I’ve never had any formal exposure to science policy. I was really excited to hear about the AAAS Science & Technology Policy Forum to learn more about how scientists can impact policy. The information I absorbed at the conference was overwhelming, but incredibly stimulating. Some of the lectures discussed the budget cuts and the depressing barriers for achieving science policy. However, I felt there was definitely an atmosphere of optimism at the conference and it was focused on how we can create positive change. One of my favorite aspects of the conference were the discussions of how to effectively communicate science to non-scientists. Before we can even have discussions of funding, the general public needs to understand how science works and why basic science is so important. For example, science never proves anything with 100%
Read more

Dr. Sarah Cavanaugh discusses biomedical research in her talk, "Homo sapiens: the ideal animal model"

By -
Image
Biology and preclinical medicine rely heavily upon research in animal models such as rodents, dogs, and chimps. But how translatable are the findings from these animal models to humans? And what alternative systems are being developed to provide more applicable results while reducing the number of research animals? Image courtesy of PCRM Last Thursday, PSPG invited Dr. Sarah Cavanaugh from the Physicians Committee for Responsible Medicine to discuss these issues. In her talk entitled, “ Homo sapiens : the ideal animal model,” she emphasized that we are not particularly good at translating results from animal models into human patients. Data from the FDA says that 90% of drugs that perform well in animal studies fail when tested in clinical trials.  It may seem obvious, but it is important to point out that the biology of mice is not identical to human biology. Scientific publications have demonstrated important dissimilarities in regards to the pathology of inflammation , d
Read more